Matthias Grass

ML x Bio @ VantAI

[Proxima @proximabio]

Join us in Seoul on Tuesday, July 7th for an evening social hosted by @proximabio, @NVIDIAHealth, @DCVC, and @Terray_Tx.

Enjoy an open bar, bites, and a curated group of researchers, founders, and investors at the intersection of AI x Bio.

Spots are limited. RSVP here: https://t.co/gDOMamqkIX

[NVIDIA Newsroom @nvidianewsroom]

Today, NVIDIA launches BioNeMo Agent Toolkit.

Backed by a decade of R&D, it adds Nemotron, NemoClaw & OpenShell to turn scientific workflows into repeatable, agent-executable tasks.

This gives any agent and AI platform the capability to synthesize knowledge, call models, reason & execute. https://t.co/lQsR7GJ9yG

[Proxima @proximabio]

Discovering proximity-based medicines means connecting many disciplines such as foundation model training, chemistry, biology, and proteomics. Powered by the NVIDIA BioNeMo Agent Toolkit, our AI agents tie these domains together, turning new biology into therapeutic hypotheses faster and moving promising programs toward patients sooner. We're proud to build that future alongside @NVIDIAHealth as they launch the BioNeMo Agent Toolkit at BIO 2026.

Links:
- BioNeMo Agent Toolkit GitHub Repo: https://t.co/7keuPsWcqq
- Blogpost: https://t.co/fgwGobprKy

[Zachary Carpenter @zwcarpenter]

Teaming up with @NVIDIAHealth this Thursday night for an NYC Tech Week Social.
Join us for open bar, small plates, music, and the people building the future of AI-meets bio!
RSVP for location
https://t.co/n7xJ2qtM7W

[Michael Bronstein @mmbronstein]

Black-box data is now on the cover of Royal Society of Chemistry

https://t.co/sEN8XTTkeM

[Proxima @proximabio]

Join us for an evening social at ICLR, hosted by @proximabio and @NVIDIAHealth

Rooftop bar, bites, and a curated room of researchers, founders, and engineers at the intersection of AI x Bio.

Spots are limited. RSVP here: https://t.co/Q12yCvxyz3

[Zachary Carpenter @zwcarpenter]

Heading to Rio for ICLR 2026 - DM me to meet up… and don’t miss our rooftop party with NVIDIA 🍹 🌅

We’re hiring!

[Proxima @proximabio]

The @proximabio team is thrilled to be at ICLR 2026 in Rio!

We're hiring Researchers and we'll be at ICLR to meet in person. If you're pushing the boundaries of generative AI x Bio, we want to talk.

Apply here and we will be in touch to schedule: https://t.co/m4YILtmwuH

[Proxima @proximabio]

Drug discovery has a scale problem. The complexes that govern signaling, regulation, and disease aren't single proteins, or even tidy pairs. They're sprawling assemblies of 10, 20, even 50+ subunits. The field is forced to sidestep that level of complexity, not for lack of interest, but for lack of tools. And yet, simulating cellular biology requires modeling the complexes and interactions these proteins form, not just individual proteins.

NeoLink, @proximabio's proteomics platform, has experimentally mapped millions of protein-protein interactions across these higher-order complexes. Predicting their structures at this scale demanded something new.

We built it with @NVIDIAHealth. By integrating NVIDIA's Fold-CP into our pipeline, we distribute computation for long biological sequences across multiple GPUs, removing the memory bottleneck that kept these complexes out of reach.

New preprint out now with the NVIDIA BioNeMo team: https://t.co/T5EBBW1piR

[Proxima @proximabio]

We are adding world-class expertise to our Scientific Advisory Board at @proximabio

Dr. Raymond Deshaies: co-inventor of PROTACs, National Academy of Sciences member, fmr SVP Global Research at Amgen
Dr. Lyn Jones (@LynJonesChemBio): molecular glue leader, fmr Head of Chemical Biology at Pfizer, PI at Dana-Farber
Dr. Juri Rappsilber (@RappsilberJuri): pioneer of cross-linking mass spectrometry, Chair of Bioanalytics at TU Berlin

We're excited to tap their deep expertise in target biology, medicinal chemistry, and structural proteomics as we build the platform for rational design of proximity-based medicines.

Press release: https://t.co/vGh8pR8hYa

[Proxima @proximabio]

Thrilled to have @DCVC and @nvidia alongside us as we build the platform for proximity-based medicines.

We're just getting started: multiple exciting announcements coming soon.

If you want to work on frontier ML models and an unprecedented biological data generation engine, we'd love to hear from you: [email protected]

[DCVC @DCVC]

.@proximabio isn’t a concept—it’s a delivery engine.

Already at $Bs in signed contracts with J&J, BMS, and Sanofi, Proxima is unlocking how protein complexes interact with real cells—rapidly, accurately, at scale.

Proud to deepen our @DCVC × @NVIDIA collaboration, backing lab-in-the-loop leaders: @Recursion, @RelationRx, and now @proximabio.

The future of drug discovery is already operational. 💥

[Proxima @proximabio]

Excited to announce that our team at Proxima (formerly VantAI) has raised $80M in new funding led by @DCVC, with @nvidia, Braidwell, @Roivant, @aixventureshq, Yosemite, Magnetic Ventures, Alexandria Venture Investments, @ModiVentures, and others.

We are building the platform for rational design of proximity-based medicines, from molecular glues to PROTACs and beyond.

Links:
Bloomberg Exclusive: https://t.co/KR7hWEPFLJ
Press Release: https://t.co/oObq3FxUJn
Website: https://t.co/dM5kl14sM8

[Proxima @proximabio]

We're thrilled to partner with @HaldaTx to expand the reach of their groundbreaking RIPTAC platform.

Together, we're working to identify new therapeutic target-effector combinations that will help enable this innovative proximity-based approach to unlock new treatment possibilities across cancer and immune disorders.

Read more: https://t.co/JTShQ3kqhr

[Matthias Grass @mtt_gra]

@nicochristie would love to have a code!

[Proxima @proximabio]

Neo just got much faster!💥

Working closely with @NVIDIAHealth, VantAI adopted #cuEquivariance, leading to massive speedups.
Today's announcement is a big advancement for the field!

[Matthias Grass @mtt_gra]

RT @vant_ai: Excited to announce our second expansion in three years with @BlueprintMeds.

Together, we will prioritize novel target-effec…

[Proxima @proximabio]

We are excited to announce the first alpha release of
💥 peppr - package for evaluation of predicted poses 💥

an open source framework for structural model evaluation

Find out more at https://t.co/mV1PHlr65H

built on @biotite_python, peppr dramatically simplifies evaluation for structure prediction and de-novo generation tasks.

We built peppr because existing evaluation tools are heavy native binaries with limited cross-platform support and hard to extend. Peppr is built on familiar python and numpy, making it highly extensible without sacrificing speed.

Built on biotite primitives, it also makes interfacing with RDKit and Biotite-based workflows much simpler.

[Proxima @proximabio]

Announcing Neo-1: the world’s most advanced atomistic foundation model, unifying structure prediction and all-atom de novo generation for the first time - to decode and design the structure of life 🧵(1/10)

[Andrew Dunn @AndrewE_Dunn]

“It tackles the big next step after AlphaFold 3,” Luca Naef, VantAI’s chief technology officer, told me.

I talked with @zwcarpenter, @NaefLuca, and @mmbronstein on VantAI's most substantive update since its 2019 start

My exclusive for @endpts on Neo-1: https://t.co/6KTRXg3vGY